Laboratory Operations At Diagnostic Sampling Tool Manufacturer Qiagen NV

Employees package Qiagen QIAxcel deoxyribonucleic acid (DNA) screening kits at the manufacturing facility of Qiagen NV in Hilden, Germany, on Friday, Aug. 22, 2014. Qiagen investors are betting the busiest year for health-care deals in more than a decade will lure acquirers to one of the industry's most expensive targets. Photographer: Jasper Juinen/Bloomberg via Getty Images
Employees package Qiagen QIAxcel deoxyribonucleic acid (DNA) screening kits at the manufacturing facility of Qiagen NV in Hilden, Germany, on Friday, Aug. 22, 2014. Qiagen investors are betting the busiest year for health-care deals in more than a decade will lure acquirers to one of the industry's most expensive targets. Photographer: Jasper Juinen/Bloomberg via Getty Images
Laboratory Operations At Diagnostic Sampling Tool Manufacturer Qiagen NV
PURCHASE A LICENSE
How can I use this image?
$499.00
USD

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
453958802
Collection:
Bloomberg
Date created:
August 22, 2014
Upload date:
License type:
Rights-managed
Release info:
Not released. More information
Source:
Bloomberg
Object name:
GERMANY QIAGEN